<DOC>
	<DOCNO>NCT00638235</DOCNO>
	<brief_summary>1 . This prospective , multi-center , post market study , conducted common protocol . 2 . The primary objective study evaluate long-term efficacy AMS Pelvic Floor Repair System device prolapse repair . 3 . The study population female subject &gt; 21 year age require surgical reconstruction pelvic floor due prolapse . 4 . The clinical data analyze compare post-treatment data baseline data , subject act control . The follow-up two year procedure . 5 . Prolapse improvement measure ICS POP-Q Stage 12-months primary endpoint study . The secondary endpoint include quality life change baseline adverse event rate .</brief_summary>
	<brief_title>Pelvic Floor Repair Systems Prolapse Repair</brief_title>
	<detailed_description />
	<mesh_term>Prolapse</mesh_term>
	<mesh_term>Pelvic Organ Prolapse</mesh_term>
	<criteria>Have diagnose one clinically significant anterior , apical posterior genital prolapse disorder ( ) ( symptomatic POPQ stage II high ) require surgical repair The Investigator determines subject candidate surgical repair genital prolapse . Subject prior prolapse implant/procedure ( i.e. , IVS tunneler , Perigee , Apogee , graft augment repair , etc ) Note : previous traditional repair allow . Subject active latent systemic infection sign tissue necrosis . Subject restrict leg motion ( inability abduct adduct leg position lithotomy position ) without hip replacement/prosthesis . Subject currently pregnant intend become pregnant study period . Note : risk benefit perform procedure subject planning future pregnancy carefully consider . Subject radiation therapy pelvic area . Subject pelvic cancer , pelvic cancer within past 12 month cytostatic medication within past 12 month . Subject know hypersensitivity graft material ( ) . Subject uncontrolled diabetes . Subject medication could result compromise immune response , immune modulators . Subject involve research trial &lt; 30 day enrollment study . Subject undergone previous pelvic surgery &lt; 6 month prior enrollment study . Subject unwilling unable give valid inform consent . Subject unwilling unable comply requirement protocol , complete Quality Life questionnaires return followup visit . Subject contraindicate base intend use warning AMS PFR System device prolapse repair Instructions Use ( IFU ) .</criteria>
	<gender>Female</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Pelvic floor repair</keyword>
	<keyword>prolapse</keyword>
	<keyword>mesh</keyword>
</DOC>